Silver Book Fact

Between 2008 and 2009, the number of Americans age 65-74 who reported trouble seeing (even with glasses or contacts) decreased from 14.3% to 10.3%.  The number of Americans age 75 and older who reported trouble seeing also decreased during that time period–from 21.1% to 16.5%.

Centers for Disease Control and Prevention. Health: United States, 2010: With special feature on death and dying. Atlanta, GA: Centers for Disease Control and Prevention; 2010. http://www.cdc.gov/nchs/data/hus/hus10.pdf

Reference

Title
Health: United States, 2010: With special feature on death and dying
Publisher
Centers for Disease Control and Prevention
Publication Date
2010
Authors
Centers for Disease Control and Prevention
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • In general, every 10 mmHg reduction in systolic blood pressure reduces the risk of diabetes complications by 12%.  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.